Koudstaal T, Funke-Chambour M, Kreuter M, Molyneaux PL, Wijsenbeek MS. Pulmonary fibrosis: from pathogenesis to clinical decision-making. Trends Mol Med. 2023;29:1076–87. https://doi.org/10.1016/j.molmed.2023.08.010.

Article  CAS  PubMed  Google Scholar 

Wijsenbeek M, Suzuki A, Maher TM. Interstitial lung diseases. Lancet. 2022;400:769–86. https://doi.org/10.1016/S0140-6736(22)01052-2.

Article  PubMed  Google Scholar 

Nasser M, Larrieu S, Si-Mohamed S, Ahmad K, Boussel L, Brevet M, et al. Progressive fibrosing interstitial lung disease: a clinical cohort (the PROGRESS study). Eur Respir J. 2021;57:2002718. https://doi.org/10.1183/13993003.02718-2020.

Article  CAS  PubMed  PubMed Central  Google Scholar 

George PM, Spagnolo P, Kreuter M, Altinisik G, Bonifazi M, Martinez FJ, et al. Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities. Lancet Respir Med. 2020;8:925–34. https://doi.org/10.1016/S2213-2600(20)30355-6.

Article  PubMed  Google Scholar 

Spagnolo P, Ryerson CJ, Putman R, Oldham J, Salisbury M, Sverzellati N, et al. Early diagnosis of fibrotic interstitial lung disease: challenges and opportunities. Lancet Respir Med. 2021;9:1065–76. https://doi.org/10.1016/S2213-2600(21)00017-5.

Article  CAS  PubMed  Google Scholar 

Cottin V, Hirani NA, Hotchkin DL, Nambiar AM, Ogura T, Otaola M, et al. Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases. Eur Respir Rev. 2018;27:180076. https://doi.org/10.1183/16000617.0076-2018.

Article  PubMed  PubMed Central  Google Scholar 

Win T, Thomas BA, Lambrou T, Hutton BF, Screaton NJ, Porter JC, et al. Areas of normal pulmonary parenchyma on HRCT exhibit increased FDG PET signal in IPF patients. Eur J Nucl Med Mol Imaging. 2014;41:337–42. https://doi.org/10.1007/s00259-013-2514-8.

Article  PubMed  Google Scholar 

Fraioli F, Lyasheva M, Porter JC, Bomanji J, Shortman RI, Endozo R, et al. Synergistic application of pulmonary 18F-FDG PET/HRCT and computer-based CT analysis with conventional severity measures to refine current risk stratification in idiopathic pulmonary fibrosis (IPF). Eur J Nucl Med Mol Imaging. 2019;46:2023–31. https://doi.org/10.1007/s00259-019-04386-5.

Article  PubMed  PubMed Central  Google Scholar 

Bondue B, Castiaux A, Van Simaeys G, Mathey C, Sherer F, Egrise D, et al. Absence of early metabolic response assessed by 18F-FDG PET/CT after initiation of antifibrotic drugs in IPF patients. Respir Res. 2019;20:10. https://doi.org/10.1186/s12931-019-0974-5.

Article  PubMed  PubMed Central  Google Scholar 

Bonnans C, Chou J, Werb Z. Remodelling the extracellular matrix in development and disease. Nat Rev Mol Cell Biol. 2014;15:786–801. https://doi.org/10.1038/nrm3904.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wynn TA, Ramalingam TR. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med. 2012;18:1028–40. https://doi.org/10.1038/nm.2807.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Habermann AC, Gutierrez AJ, Bui LT, Yahn SL, Winters NI, Calvi CL. Single-cell RNA sequencing reveals profibrotic roles of distinct epithelial and mesenchymal lineages in pulmonary fibrosis. Sci Adv. 2020;6:eaba1972. https://doi.org/10.1126/sciadv.aba1972.

Désogère P, Tapias LF, Hariri LP, Rotile NJ, Rietz TA, Probst CK. Type I collagen-targeted PET probe for pulmonary fibrosis detection and staging in preclinical models. Sci Transl Med. 2017;9:eaaf4696. https://doi.org/10.1126/scitranslmed.aaf4696.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Désogère P, Tapias LF, Rietz TA, Rotile N, Blasi F, Day H, et al. Optimization of a collagen-targeted PET probe for molecular imaging of pulmonary fibrosis. J Nucl Med. 2017;58:1991–6. https://doi.org/10.2967/jnumed.117.193532.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Izquierdo-Garcia D, Désogère P, Fur ML, Shuvaev S, Zhou IY, Ramsay I, et al. Biodistribution, dosimetry, and pharmacokinetics of 68Ga-CBP8: a type I collagen-targeted PET probe. J Nucl Med. 2023;64:775–81. https://doi.org/10.2967/jnumed.122.264530.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rosestedt M, Velikyan I, Rosenström U, Estrada S, Åberg O, Weis J, et al. Radiolabelling and Positron emission tomography imaging of a high-affinity peptide binder to collagen type 1. Nucl Med Biol. 2021;93:54–62. https://doi.org/10.1016/j.nucmedbio.2020.11.006.

Article  CAS  PubMed  Google Scholar 

Broens B, Duitman JW, Zwezerijnen GJC, Nossent EJ, van der Laken CJ, Voskuyl AE. Novel tracers for molecular imaging of interstitial lung disease: a state of the art review. Autoimmun Rev. 2022;21:103202. https://doi.org/10.1016/j.autrev.2022.103202.

Article  CAS  PubMed  Google Scholar 

Goldenberg DM, Sharkey RM, McBride WJ, Boerman OC. Al18F: a new standard for radiofluorination. J Nucl Med. 2013;54:1170. https://doi.org/10.2967/jnumed.113.125245.

Article  PubMed  Google Scholar 

Li H, Ye S, Li Li, Zhong J, Yan Q, Zhong Y, et al. 18F- or 177Lu-Labeled bivalent ligand of fibroblast activation protein with high tumor uptake and retention. Eur J Nucl Med Mol Imaging. 2022;49:2705–15. https://doi.org/10.1007/s00259-022-05757-1.

Article  CAS  PubMed  Google Scholar 

Caravan P, Das B, Dumas S, Epstein FH, Helm PA, Jacques V, et al. Collagen-targeted MRI contrast agent for molecular imaging of fibrosis. Angew Chem Int Ed Engl. 2007;46:8171–3. https://doi.org/10.1002/anie.200700700.

Article  CAS  PubMed  Google Scholar 

Loktev A, Lindner T, Mier W, Debus J, Altmann A, Jäger D, et al. A tumor-imaging method targeting cancer-associated fibroblasts. J Nucl Med. 2018;59:1423–9. https://doi.org/10.2967/jnumed.118.210435.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tanguy J, Goirand F, Bouchard A, Frenay J, Moreau M, Mothes C, et al. [18F]FMISO PET/CT imaging of hypoxia as a non-invasive biomarker of disease progression and therapy efficacy in a preclinical model of pulmonary fibrosis: comparison with the [18F]FDG PET/CT approach. Eur J Nucl Med Mol Imaging. 2021;48:3058–74. https://doi.org/10.1007/s00259-021-05209-2.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hübner RH, Gitter W, El Mokhtari NE, Mathiak M, Both M, Bolte H, et al. Standardized quantification of pulmonary fibrosis in histological samples. Biotechniques. 2008;44:507–17. https://doi.org/10.2144/000112729.

Article  CAS  PubMed  Google Scholar 

Stritt M, Stalder AK, Vezzali E. Orbit image analysis: an open-source whole slide image analysis tool. PLoS Comput Biol. 2020;16:e1007313. https://doi.org/10.1371/journal.pcbi.1007313.

Article  CAS  PubMed  PubMed Central  Google Scholar 

King TE Jr, Pardo A, Selman M. Idiopathic pulmonary fibrosis. Lancet. 2011;378:1949–61. https://doi.org/10.1016/S0140-6736(11)60052-4.

Article  PubMed  Google Scholar 

Schiller HB, Fernandez IE, Burgstaller G, Schaab C, Scheltema RA, Schwarzmayr T, et al. Time- and compartment-resolved proteome profiling of the extracellular niche in lung injury and repair. Mol Syst Biol. 2015;11:819. https://doi.org/10.15252/msb.20156123.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moore BB, Hogaboam CM. Murine models of pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2008;294:L152–60. https://doi.org/10.1152/ajplung.00313.2007.

Article  CAS  PubMed